Clinical Trials Browser

Phase 2/3 × NET × 30 days × Clear all

NCT05749289 2026-04-06

Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression

Phase 2/3 Recruiting

Neuroendocrine Tumors

NCT06943755 2026-03-24

STELLAR-311

Phase 2/3 Recruiting

Adenoma, Islet Cell, Neoplasm Metastasis, Neuroendocrine Tumors